These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 482196)

  • 1. Diabetes and the insulin routine.
    Bloom A
    Postgrad Med J; 1979; 55 Suppl 2():27-30. PubMed ID: 482196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Respective contributions of the method of insulin injection and its absorption by subcutaneous route in the etiopathogenesis of unstable diabetes].
    Home PD
    Journ Annu Diabetol Hotel Dieu; 1995; ():243-55. PubMed ID: 7602885
    [No Abstract]   [Full Text] [Related]  

  • 3. [Trust is good, control is better. Glucose tests, insulin syringes, needles].
    Fink E
    Pharm Unserer Zeit; 2001 Jan; 30(1):34-9. PubMed ID: 11233181
    [No Abstract]   [Full Text] [Related]  

  • 4. Subcutaneous use of regular human insulin (Novo): pharmacokinetics and continuous insulin infusion therapy.
    Sonnenberg GE; Kemmer FW; Cüppers HJ; Berger M
    Diabetes Care; 1983; 6 Suppl 1():35-9. PubMed ID: 6343035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Human insulin. Subcutaneous absorption, receptor binding and blood glucose control in diabetics].
    Sestoft L; Birch K; Gammeltoft S; Hildebrandt P; Vølund A
    Ugeskr Laeger; 1983 Jun; 145(24):1843-6. PubMed ID: 6351391
    [No Abstract]   [Full Text] [Related]  

  • 6. Insulin therapy during peritoneal dialysis: pros and cons of various forms of administration.
    Quellhorst E
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S92-6. PubMed ID: 11792768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin analog lispro decreases insulin resistance and improves glycemic control in an obese patient with insulin-requiring type 2 diabetes.
    Darmon P; Curtillet C; Boullu S; Laugier A; Dutour A; Oliver C
    Diabetes Care; 1998 Sep; 21(9):1575. PubMed ID: 9727917
    [No Abstract]   [Full Text] [Related]  

  • 8. The biological properties of human insulin. Subcutaneous absorption, receptor binding and the clinical effect in diabetics assessed by a new statistical method.
    Sestoft L; Vølund A; Gammeltoft S; Birch K; Hildebrandt P
    Acta Med Scand; 1982; 212(1-2):21-8. PubMed ID: 6751025
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetic and clinical aspects of intensified subcutaneous insulin therapy.
    Lauritzen T
    Dan Med Bull; 1985 May; 32(2):104-18. PubMed ID: 3924487
    [No Abstract]   [Full Text] [Related]  

  • 10. [Proceedings: Formation of anti-insulin antibodies IgG in diabetic patients treated with conventional insulin monocomposed or monospecific].
    Weber HU; Sourisseau D; Zahnd GR
    Helv Med Acta; 1974 May; 37(5-6):367. PubMed ID: 4410557
    [No Abstract]   [Full Text] [Related]  

  • 11. Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Influence of species, physico-chemical properties of insulin and physiological factors.
    Hildebrandt P
    Dan Med Bull; 1991 Aug; 38(4):337-46. PubMed ID: 1914533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Closed-loop insulin delivery - what lies between where we are and where we are going?
    Steil GM; Rebrin K
    Expert Opin Drug Deliv; 2005 Mar; 2(2):353-62. PubMed ID: 16296759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled human insulin: new drug. No short-term advantages, too many unknowns in the long term.
    Prescrire Int; 2006 Dec; 15(86):203-9. PubMed ID: 17165235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Insulin therapy today].
    Willms B
    Internist (Berl); 1981 Apr; 22(4):211-8. PubMed ID: 7014510
    [No Abstract]   [Full Text] [Related]  

  • 15. Circulating insulin antibodies: influence of continuous subcutaneous or intraperitoneal insulin infusion, and impact on glucose control.
    Radermecker RP; Renard E; Scheen AJ
    Diabetes Metab Res Rev; 2009 Sep; 25(6):491-501. PubMed ID: 19496088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unlocking the opportunity of tight glycaemic control. Far from goal.
    Del Prato S
    Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S1-4. PubMed ID: 16135133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes Clinical Care Conference: survival techniques in diabetes mellitus.
    J Tenn Med Assoc; 1981 Mar; 74(3):193-6, 196. PubMed ID: 7024645
    [No Abstract]   [Full Text] [Related]  

  • 18. Replacement treatment with insulin in diabetes mellitus: problems and promise.
    Dupre J; Champion MC; Rodger NW
    Clin Invest Med; 1982; 5(2-3):109-19. PubMed ID: 6749365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous absorption of U-40 and U-100 insulin.
    Lauritzen T; Thorsteinsson B; Pramming S; Sørensen L; Binder C
    Horm Metab Res; 1984 Nov; 16(11):611-2. PubMed ID: 6392055
    [No Abstract]   [Full Text] [Related]  

  • 20. Liver disease, insulin antagonism and diabetes mellitus.
    Creutzfeldt W; Frerichs H; Kneer P
    Horm Metab Res; 1974; Suppl 4():135-42. PubMed ID: 4423508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.